share_log

诚志股份(000990.SZ):合成生物业务为公司生命医疗板块的主营业务之一

Chengzhi Co., Ltd. (000990.SZ): The synthetic biology business is one of the company's main businesses in the biomedical sector

Gelonghui Finance ·  May 9 04:49

Gelonghui, May 9 | Chengzhi Co., Ltd. (000990.SZ) said on the investor interactive platform that the synthetic biology business is one of the company's main businesses in the biomedical sector. Among them, production and sales of the company's D-ribose series products have grown rapidly in recent years. Currently, they dominate the global market and are widely used in medicine, nutrition and health care, food and beverage, clinical nutrition, etc. D-mannose developed by the company was mass-produced in 2023, and product sales have been growing steadily.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment